tecogalan
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00002137)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Acidic fibroblast growth factorINHIBITOR
FGF1 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108789 ↗
Also known as
- d-gluco-d-galactan sulfate
- ds 4152
- ds-4152
- ds-4152
- tecogalan
- tecogalan sodium
- tecogalan sodium
- tecogalan sodium
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00002136 | Phase 1 | Nov 2, 1999 | Daiichi |
| NCT00002137 | Phase 1 | Nov 2, 1999 | Daiichi |
| NCT00002138 | Phase 1 | Nov 2, 1999 | Daiichi |
| NCT00002342 | Phase 1 | Nov 2, 1999 | Daiichi |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Daiichi | For profit | 4 | 4 | 1 | 1999 |
1 organizations
Page 1 / 1